PAA Board Changes 09/05/24 PRICE SENSITIVE download Created with Sketch. 212.89KB Share PAA Trading Halt 07/05/24 PRICE SENSITIVE download Created with Sketch. 550.73KB Share PAA Appendix 4C & Quarterly Update 30/04/24 PRICE SENSITIVE download Created with Sketch. 330.66KB Share PAA Resignation of Dr Michael Thurn & appointment of John Clark 23/04/24 PRICE SENSITIVE download Created with Sketch. 209.88KB Share PAA Final Ethics Approval for Open-Label MND Extension Study 10/04/24 PRICE SENSITIVE download Created with Sketch. 242.16KB Share PAA Media clarification 02/04/24 PRICE SENSITIVE download Created with Sketch. 182.78KB Share PAA Trading Halt 02/04/24 PRICE SENSITIVE download Created with Sketch. 192.63KB Share PAA Pause in Trading 02/04/24 PRICE SENSITIVE download Created with Sketch. 115.56KB Share PAA Positive clinical data filed with FDA to support ODD request 14/03/24 PRICE SENSITIVE download Created with Sketch. 195.8KB Share PAA Appendix 4D & Half-Year Report 29/02/24 PRICE SENSITIVE download Created with Sketch. 637.51KB Share PAA Presentation - Phase 1 Top-Line Results 27/02/24 PRICE SENSITIVE download Created with Sketch. 1.11MB Share PAA Positive Phase 1 MEND Study Top-Line Results 27/02/24 PRICE SENSITIVE download Created with Sketch. 265.55KB Share PAA Trading Halt 26/02/24 PRICE SENSITIVE download Created with Sketch. 555.56KB Share PAA PharmAust Forms World-Class Scientific Advisory Board 22/02/24 PRICE SENSITIVE download Created with Sketch. 196.22KB Share PAA FDA Outlines Pathway to Accelerated Approval for MPL in MND 16/02/24 PRICE SENSITIVE download Created with Sketch. 155.77KB Share PAA Extension Study Begins, Analysis Suggests Survival Benefit 14/02/24 PRICE SENSITIVE download Created with Sketch. 349.96KB Share PAA Appendix 4C & Quarterly Update 31/01/24 PRICE SENSITIVE download Created with Sketch. 298.03KB Share PAA Ethics Committee Approval for Open-Label MND Extension Study 30/01/24 PRICE SENSITIVE download Created with Sketch. 189.05KB Share PAA FDA Provides Clear Feedback for ODD Approval 29/01/24 PRICE SENSITIVE download Created with Sketch. 155.4KB Share PAA PharmAust Partners with Berry Consultants for MND Phase 2/3 16/01/24 PRICE SENSITIVE download Created with Sketch. 158.48KB Share PAA FDA Grants PharmAust Pre-IND Meeting 02/01/24 PRICE SENSITIVE download Created with Sketch. 156.3KB Share PAA FightMND Invites PharmAust to Apply for Phase 2/3 Funding 22/12/23 PRICE SENSITIVE download Created with Sketch. 154.99KB Share PAA PharmAust Receives R&D Tax Incentive Refund 20/12/23 PRICE SENSITIVE download Created with Sketch. 152.85KB Share PAA 93% take up in Options Offer 15/12/23 PRICE SENSITIVE download Created with Sketch. 154.54KB Share PAA PharmAust Raises $3.5 Million at a Premium 13/12/23 PRICE SENSITIVE download Created with Sketch. 170.98KB Share PAA Trading Halt 11/12/23 PRICE SENSITIVE download Created with Sketch. 549.26KB Share PAA PAA completes Phase 1 and files for Orphan Drug Designation 01/12/23 PRICE SENSITIVE download Created with Sketch. 184.1KB Share PAA Prospectus & Target Market Determination 21/11/23 PRICE SENSITIVE download Created with Sketch. 423KB Share PAA Appendix 4C and Quarterly Update 30/10/23 PRICE SENSITIVE download Created with Sketch. 3.11MB Share PAA Options Offer to Existing Listed Option Holders 18/10/23 PRICE SENSITIVE download Created with Sketch. 331.86KB Share PAA Final MND Patient in Cohort 4 Successfully Completes Dosing 13/10/23 PRICE SENSITIVE download Created with Sketch. 226.42KB Share PAA Canine Oncology Data Supports Progression to Registration 09/10/23 PRICE SENSITIVE download Created with Sketch. 1.18MB Share PAA Trading Halt 06/10/23 PRICE SENSITIVE download Created with Sketch. 524.8KB Share PAA Appendix 4E & Full Year Statutory Accounts 31/08/23 PRICE SENSITIVE download Created with Sketch. 1.21MB Share PAA Chief Executive Officer Appointment 28/08/23 PRICE SENSITIVE download Created with Sketch. 209.6KB Share PAA Additional Phase 1 data suggest MPL may inhibit MND 22/08/23 PRICE SENSITIVE download Created with Sketch. 351.67KB Share PAA Trading Halt 17/08/23 PRICE SENSITIVE download Created with Sketch. 552.24KB Share PAA Cohort 3 Pharmacokinetics in MND Patients Completed 09/08/23 PRICE SENSITIVE download Created with Sketch. 305.56KB Share PAA Epichem enters voluntary liquidation 01/08/23 PRICE SENSITIVE download Created with Sketch. 149.19KB Share PAA Appendix 4C and Quarterly Update 31/07/23 PRICE SENSITIVE download Created with Sketch. 1.58MB Share PAA MND Trial Successfully Completes 3rd Patient Cohort 28/07/23 PRICE SENSITIVE download Created with Sketch. 183.55KB Share PAA Canine Trial Update 13/07/23 PRICE SENSITIVE download Created with Sketch. 1.23MB Share PAA Results show MPL suppresses biomarkers associated with MND 11/07/23 PRICE SENSITIVE download Created with Sketch. 248.2KB Share PAA Trading Halt 10/07/23 PRICE SENSITIVE download Created with Sketch. 575.59KB Share PAA Louie the Beagle surpasses one year on MPL 06/07/23 PRICE SENSITIVE download Created with Sketch. 440.49KB Share PAA MND Biomarkers and Pharmacodynamics Results 04/07/23 PRICE SENSITIVE download Created with Sketch. 341.97KB Share PAA Trading Halt 30/06/23 PRICE SENSITIVE download Created with Sketch. 217.47KB Share PAA Motor Neurone Disease Phase 1/2 Clinical Trial Update 27/06/23 PRICE SENSITIVE download Created with Sketch. 209.8KB Share PAA PharmAust MND Trial Interim Analysis PK Outcomes 07/06/23 PRICE SENSITIVE download Created with Sketch. 364.64KB Share PAA Trading Halt 05/06/23 PRICE SENSITIVE download Created with Sketch. 578.64KB Share PAA Motor Neurone Disease Clinical Trial Update 22/05/23 PRICE SENSITIVE download Created with Sketch. 206.61KB Share PAA Progress update on Phase 1/2 MND interim analysis 16/05/23 PRICE SENSITIVE download Created with Sketch. 258.68KB Share PAA Independent tests show MPL retains long-term shelf-life 10/05/23 PRICE SENSITIVE download Created with Sketch. 274.33KB Share PAA MPL has anti-cancer effects across multiple cancer types 09/05/23 PRICE SENSITIVE download Created with Sketch. 655.11KB Share PAA PharmAust Raises $2.5m via Placement 03/05/23 PRICE SENSITIVE download Created with Sketch. 205.33KB Share PAA Appendix 4C and Quarterly Update 28/04/23 PRICE SENSITIVE download Created with Sketch. 1.24MB Share PAA Trading Halt 28/04/23 PRICE SENSITIVE download Created with Sketch. 577.21KB Share PAA MND Trial Successfully Completes Second Patient Cohort 28/04/23 PRICE SENSITIVE download Created with Sketch. 231.89KB Share PAA Canine Trial Update 21/04/23 PRICE SENSITIVE download Created with Sketch. 1.42MB Share PAA Arrival of additional MPL tablets 17/04/23 PRICE SENSITIVE download Created with Sketch. 227.21KB Share PAA PharmAust launches international CEO search 13/04/23 PRICE SENSITIVE download Created with Sketch. 234.9KB Share PAA MND Trial Completes Enrolment of Cohort 2 30/03/23 PRICE SENSITIVE download Created with Sketch. 209.15KB Share PAA Stable Patient in MND trial reaches 6-months on MPL 28/03/23 PRICE SENSITIVE download Created with Sketch. 200.46KB Share PAA Canine Cancer Trial Update 07/03/23 PRICE SENSITIVE download Created with Sketch. 351.24KB Share PAA Interim analysis recommended in MND trial 02/03/23 PRICE SENSITIVE download Created with Sketch. 253.45KB Share PAA European Patent relating to MPL Combinations in Cancer 28/02/23 PRICE SENSITIVE download Created with Sketch. 202KB Share PAA Appendix 4D & Half Year Report 27/02/23 PRICE SENSITIVE download Created with Sketch. 464.1KB Share PAA First Patient of Cohort 2 Dosed in MND Trial 20/02/23 PRICE SENSITIVE download Created with Sketch. 263.75KB Share PAA PharmAust canine trial update 10/02/23 PRICE SENSITIVE download Created with Sketch. 2.39MB Share PAA Appendix 4C and Quarterly Update 30/01/23 PRICE SENSITIVE download Created with Sketch. 2.77MB Share PAA PharmAust Progresses to Elevated Doses in MND Patients 20/01/23 PRICE SENSITIVE download Created with Sketch. 198.44KB Share PAA MND Trial Successfully Completes First Patient Cohort 06/01/23 PRICE SENSITIVE download Created with Sketch. 325.82KB Share PAA PharmAust Canine Trial Update clarification 20/12/22 PRICE SENSITIVE download Created with Sketch. 3.29MB Share PAA PharmAust Canine Trial Update 20/12/22 PRICE SENSITIVE download Created with Sketch. 3.2MB Share PAA PharmAust Receives R&D Tax Incentive Refund 12/12/22 PRICE SENSITIVE download Created with Sketch. 185.99KB Share PAA MND Trial Completes Enrolment of First Patient Cohort 02/12/22 PRICE SENSITIVE download Created with Sketch. 252.5KB Share PAA DNDi contract extension for PharmAust subsidiary Epichem 03/11/22 PRICE SENSITIVE download Created with Sketch. 250.21KB Share PAA Appendix 4C and Quarterly Update 31/10/22 PRICE SENSITIVE download Created with Sketch. 2.31MB Share PAA First Patient Dosed in MND Phase 1/2 Trial 03/10/22 PRICE SENSITIVE download Created with Sketch. 213.96KB Share PAA First Patient in US Canine Cancer Trials Begins Treatment 07/09/22 PRICE SENSITIVE download Created with Sketch. 209.08KB Share PAA Appendix 4E & Full Year Statutory Accounts 26/08/22 PRICE SENSITIVE download Created with Sketch. 1.5MB Share PAA Update on PharmAust Canine Cancer Trials 17/08/22 PRICE SENSITIVE download Created with Sketch. 375.4KB Share PAA Appendix 4C and Quarterly Update 20/07/22 PRICE SENSITIVE download Created with Sketch. 634.05KB Share PAA PharmAust Clinical Trials Update 24/05/22 PRICE SENSITIVE download Created with Sketch. 221.67KB Share PAA PharmAust receives $210k prepayment of forecast R&D rebate 17/05/22 PRICE SENSITIVE download Created with Sketch. 188.38KB Share PAA MPL tablets arrive in Melbourne for MND Clinical Trial 16/05/22 PRICE SENSITIVE download Created with Sketch. 219.07KB Share PAA PharmAust Expands Lymphoma Canine Trial to the USA 11/05/22 PRICE SENSITIVE download Created with Sketch. 222.32KB Share PAA Appendix 4C and Quarterly Update 29/04/22 PRICE SENSITIVE download Created with Sketch. 860.4KB Share PAA PharmAust Receives $708k R&D Tax Incentive Refund 19/04/22 PRICE SENSITIVE download Created with Sketch. 187.5KB Share PAA PAA appoints trial manager & receives $200k from FightMND 08/04/22 PRICE SENSITIVE download Created with Sketch. 219.61KB Share PAA MPL manufactured and tableting commenced 15/03/22 PRICE SENSITIVE download Created with Sketch. 212.64KB Share PAA Preliminary MPL antiviral leukaemia preclinical WEHI results 23/02/22 PRICE SENSITIVE download Created with Sketch. 243.37KB Share PAA Key Appointment to Progress MPL COVID-19 Clinical Trial 21/02/22 PRICE SENSITIVE download Created with Sketch. 316.4KB Share PAA Appendix 4D & Half Year Report 18/02/22 PRICE SENSITIVE download Created with Sketch. 1.08MB Share PAA Epichem Confirms Effectiveness of OHD E-Waste Project 16/02/22 PRICE SENSITIVE download Created with Sketch. 224KB Share PAA Update on Manufacture of MPL & Tablets for Clinical Trials 02/02/22 PRICE SENSITIVE download Created with Sketch. 202.99KB Share PAA Appendix 4C and Quarterly Update 31/01/22 PRICE SENSITIVE download Created with Sketch. 848.78KB Share PAA Epichem Awarded Contract Extension from DNDi 15/12/21 PRICE SENSITIVE download Created with Sketch. 489.68KB Share PAA Shareholder Update - Progress and Strategy 13/12/21 PRICE SENSITIVE download Created with Sketch. 576.5KB Share PAA Demonstration batch of smaller size MPL tablets completed 01/12/21 PRICE SENSITIVE download Created with Sketch. 275.41KB Share
(20min delay)
